2-Fluoromethamphetamine (2-FMA) is a stimulant medication of the amphetamine family that has been utilized as a designer drug. It is supposed to have little recreational value because less euphoria is produced than other amphetamines. It is reportedly a functional stimulant with properties similar to lisdexamfetamine.
It lasts about 8 hours, considerably over its analog 2-FA.
2-Fluoromethamphetamine (also called 2-FMA) is a novel stimulant substance of the amphetamine class. It’s a structural analog of methamphetamine and is related to 2-FA, 3-FA, and 4-FMA. 2-FMA produces its stimulant effects throughout action at dopamine and norepinephrine receptors in the mind.
The selling of 2-FMA on the online research chemical market was initially reported in August 2007. It seemed along with other fluorinated amphetamines like 2-FA and 4-FA. It seems to be unknown in the research and clinical literature.
Subjective effects include stimulation, concentrate enhancement, motivation enhancement, increased libido, appetite suppression, and chills. It is often taken either orally or via insufflation and is reported to be highly unpleasant to vaporize. 2-FMA is often compared to lisdexamfetamine (Vyvanse) in its duration, potency and efficiency as a study or productivity aid. A considerable increase in adverse effects such as high blood pressure and increased heart rate tends to be reported for dosages above the heavy dose array.
Molecules of the amphetamine class contain a phenethylamine core featuring a phenyl ring bound into an amino (NH2) group through an ethyl series having an additional methyl substitution at Rα (i.e., amphetamines are alpha-methylated phenethylamines). 2-FMA contains a methyl group bound to the terminal amine RN of the amphetamine core, a substitution it shares with methamphetamine.
Though 2-FMA hasn’t been formally researched on precisely the same level as traditional amphetamines, it’s believed that it functions as either a dopamine and norepinephrine publishing agent. This means it effectively raises the degree of the norepinephrine and dopamine in the brain by binding to partially blocking the transporter proteins that normally remove them from the synaptic cleft. This permits dopamine and norepinephrine to accumulate within the mind, leading to soothing and stimulating effects.
It’s regarded as a practical stimulant for performing overall productivity tasks in a way very similar to amphetamine or lisdexamfetamine (Vyvanse). However, at higher doses, it typically loses its productivity and focus-enhancing results and starts to take on a recreational character due to the distracting euphoria that it may produce. The majority of users report through anecdotal reports that this has a ceiling effect with a higher dose (Heavy+) ranges where lots of report of the embarrassing effects from stimulants if passing or entering the strong-heavy dose range.